CBIO

Crescent Biopharma
CBIO

36 hedge funds and large institutions have $230M invested in Crescent Biopharma in 2014 Q1 according to their latest regulatory filings, with 36 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed
Holders
36
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$140M
2
+$40M
3
+$14.6M
4
CAM
Cormorant Asset Management
Massachusetts
+$7.67M
5
DCM
Driehaus Capital Management
Illinois
+$3.88M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$305K
27
$242K
28
$238K
29
$213K
30
$180K
31
$22K
32
$13K
33
$11K
34
$4K
35
$3K
36
$2K
1
2